NTES [NetEase] 6-K: (Original Filing)

[Press Release Contact for Media and Investors: Brandi Piacente Investor Relations brandi@corp.netease.com Tel: (+1) 212-481-2050 Cassia Curran NetEase,Inc. cassia@corp.netease.com Tel: (+86) 571-8985-2076 NetEase Reports First Quarter 2012 Unaudited Financial Results (Beijing May16, 2012) NetEase,Inc. (NASDAQ: NTES), one of Chinas leading Internet and online game services providers, today announced its unaudited financial results for the first]

By | 2016-01-10T16:02:19+00:00 May 17th, 2012|Categories: Chinese Stocks, NTES, SEC Original|Tags: , , , , , |0 Comments

CJJD [CHINA JO-JO DRUGSTORES] 8-K: (Original Filing)

[CONSULTING SERVICES AGREEMENT Agreement Parties This Consulting Services Agreement (this “ RECITALS (1) Party A, a company incorporated in the PRC as a foreign invested enterprise, specializes in enterprise management and consultation; (2) Party B is mainly engaged in retail of prescription and non-prescription drugs including traditional Chinese medicinal materials, Chinese prepared medicines, cut crude drugs, pharmaceutical chemicals, antibiotics, biochemical] [OPERATING AGREEMENT Ag This Operating Agreement (this “ RECITALS 1. Party A, a company incorporated in the PRC as a foreign invested enterprise, specializes in enterprise management and consultation; Business 2. Party B is engaged in retail of prescription and non-prescription drugs including traditional Chinese medicinal materials, Chinese prepared medicines, cut crude drugs, pharmaceutical chemicals, antibiotics, biochemical drugs, and biological] [VOTING RIGHTS PROXY AGREEMENT Agreement PRC China Party A Party Parties This Voting Rights Proxy Agreement (the “ RECITALS 1. Party A, a company incorporated in the PRC as a foreign invested enterprise, specializes in enterprise management and consultation (collectively the “Business”). Party A and the Company have entered into a certain Consulting Services Agreement dated May 15, 2012 (the] [EQUITY PLEDGE AGREEMENT Agreement PRC China Pledgee Company Pledgor Pledgors Party Parties This Equity Pledge Agreement (hereinafter this “ RECITALS 1. The Pledgee incorporated in the PRC as a foreign invested enterprise and specializes in enterprise management and consultation. 2. Business The Company is engaged in retail of prescription and non-prescription drugs including traditional Chinese medicinal materials, Chinese prepared medicines,] [OPTION AGREEMENT This Option Agreement (this “Agreement”) is dated May 15, 2012, and is entered into in Hangzhou City, People’s Republic of China (“PRC” or “China”) by and among Zhejiang Jiuxin Investment Management Co., Ltd (“Party A”) and Zhejiang Jiuying Grand Pharmacy Co., Ltd. (“Company” or “Party B”), the individual shareholders collectively holding 51% of the issued and outstanding equity] [China Jo-Jo Drugstores Announces New Store Openings in Shanghai and Hangzhou HANGZHOU, China--(BUSINESS WIRE)--May 17, 2012--China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) (the “Company”), a retail pharmacy chain in Zhejiang and Shanghai, today announced two new store openings in Shanghai and Hangzhou, increasing the Company’s total store count to 61. Three additional stores are planned to be opened in Hangzhou by mid-2012.]

FFHL [Fuwei Films] 6-K: (Original Filing)

[Fuwei Films Announces Its Unaudited Financial -Teleconference to be Held on May 16, 2012, at 9:00 a.m. EDT- BEIJING, May 15, 2012 Highlights § Revenues were RMB91.0 million (US$14.5 million), compared with RMB174.2 million in the same period of 2011. § Net loss attributable to the Company was RMB15.1 million (US$2.4 million), compared with net income attributable to the Company] []

By | 2016-03-27T05:45:36+00:00 May 17th, 2012|Categories: Chinese Stocks, FFHL, SEC Original|Tags: , , , , , |0 Comments

NTES [NetEase] 6-K: Press Release Contact for Media and Investors: Brandi

[Press Release Contact for Media and Investors: Brandi Piacente Investor Relations brandi@corp.netease.com Tel: (+1) 212-481-2050 Cassia Curran NetEase,Inc. cassia@corp.netease.com Tel: (+86) 571-8985-2076 NetEase Reports First Quarter 2012 Unaudited Financial Results (Beijing May16, 2012) NetEase,Inc. (NASDAQ: NTES), one of Chinas leading Internet and online game services providers, today announced its unaudited financial results for the first]

By | 2016-01-10T16:02:30+00:00 May 17th, 2012|Categories: Chinese Stocks, NTES, Webplus ver|Tags: , , , , , |0 Comments

CJJD [CHINA JO-JO DRUGSTORES] 8-K: CONSULTING SERVICES AGREEMENT Agreement Parties This Consulting Services

[CONSULTING SERVICES AGREEMENT Agreement Parties This Consulting Services Agreement (this “ RECITALS (1) Party A, a company incorporated in the PRC as a foreign invested enterprise, specializes in enterprise management and consultation; (2) Party B is mainly engaged in retail of prescription and non-prescription drugs including traditional Chinese medicinal materials, Chinese prepared medicines, cut crude drugs, pharmaceutical chemicals, antibiotics, biochemical] [OPERATING AGREEMENT Ag This Operating Agreement (this “ RECITALS 1. Party A, a company incorporated in the PRC as a foreign invested enterprise, specializes in enterprise management and consultation; Business 2. Party B is engaged in retail of prescription and non-prescription drugs including traditional Chinese medicinal materials, Chinese prepared medicines, cut crude drugs, pharmaceutical chemicals, antibiotics, biochemical drugs, and biological] [VOTING RIGHTS PROXY AGREEMENT Agreement PRC China Party A Party Parties This Voting Rights Proxy Agreement (the “ RECITALS 1. Party A, a company incorporated in the PRC as a foreign invested enterprise, specializes in enterprise management and consultation (collectively the “Business”). Party A and the Company have entered into a certain Consulting Services Agreement dated May 15, 2012 (the] [EQUITY PLEDGE AGREEMENT Agreement PRC China Pledgee Company Pledgor Pledgors Party Parties This Equity Pledge Agreement (hereinafter this “ RECITALS 1. The Pledgee incorporated in the PRC as a foreign invested enterprise and specializes in enterprise management and consultation. 2. Business The Company is engaged in retail of prescription and non-prescription drugs including traditional Chinese medicinal materials, Chinese prepared medicines,] [OPTION AGREEMENT This Option Agreement (this “Agreement”) is dated May 15, 2012, and is entered into in Hangzhou City, People’s Republic of China (“PRC” or “China”) by and among Zhejiang Jiuxin Investment Management Co., Ltd (“Party A”) and Zhejiang Jiuying Grand Pharmacy Co., Ltd. (“Company” or “Party B”), the individual shareholders collectively holding 51% of the issued and outstanding equity] [China Jo-Jo Drugstores Announces New Store Openings in Shanghai and Hangzhou HANGZHOU, China--(BUSINESS WIRE)--May 17, 2012--China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) (the “Company”), a retail pharmacy chain in Zhejiang and Shanghai, today announced two new store openings in Shanghai and Hangzhou, increasing the Company’s total store count to 61. Three additional stores are planned to be opened in Hangzhou by mid-2012.]

FFHL [Fuwei Films] 6-K: Fuwei Films Announces Its Unaudited Financial -Teleconference to

[Fuwei Films Announces Its Unaudited Financial -Teleconference to be Held on May 16, 2012, at 9:00 a.m. EDT- BEIJING, May 15, 2012 Highlights § Revenues were RMB91.0 million (US$14.5 million), compared with RMB174.2 million in the same period of 2011. § Net loss attributable to the Company was RMB15.1 million (US$2.4 million), compared with net income attributable to the Company] []

By | 2016-03-27T05:47:02+00:00 May 17th, 2012|Categories: Chinese Stocks, FFHL, Webplus ver|Tags: , , , , , |0 Comments

TPI [TIANYIN PHARMACEUTICAL] 8-K: (Original Filing)

[TPI Reports Third Quarter Fiscal Year 2012 Financial Results CHENGDU, China, May 15, 2012 -- Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for the third quarter of fiscal year 2012. Third Quarter Fiscal Year 2012 Ended March] [Tianyin Pharmaceutical Co., Inc. (TPI) F3Q12 Earnings Call May 15, 2012 9:00 AM ET Operator Good day ladies and gentlemen thank you for standing by. Welcome to the Tianyin Pharmaceutical Incorporated Third quarter fiscal 2012 annual financial results conference call. During today’s presentation, all parties will be in a listen-only mode. Following the presentation, the conference will be opened for] [CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT May 17, 2012 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction (IRS Employer of incorporation) Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 o o o]

By | 2016-03-27T19:25:24+00:00 May 17th, 2012|Categories: Chinese Stocks, SEC Original, TPI|Tags: , , , , , |0 Comments

TPI [TIANYIN PHARMACEUTICAL] 8-K: TPI Reports Third Quarter Fiscal Year 2012 Financial

[TPI Reports Third Quarter Fiscal Year 2012 Financial Results CHENGDU, China, May 15, 2012 -- Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for the third quarter of fiscal year 2012. Third Quarter Fiscal Year 2012 Ended March] [Tianyin Pharmaceutical Co., Inc. (TPI) F3Q12 Earnings Call May 15, 2012 9:00 AM ET Operator Good day ladies and gentlemen thank you for standing by. Welcome to the Tianyin Pharmaceutical Incorporated Third quarter fiscal 2012 annual financial results conference call. During today’s presentation, all parties will be in a listen-only mode. Following the presentation, the conference will be opened for] [CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT May 17, 2012 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction (IRS Employer of incorporation) Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 o o o]

By | 2016-03-27T19:27:17+00:00 May 17th, 2012|Categories: Chinese Stocks, TPI, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar